Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
Rev. Asoc. Odontol. Argent ; 98(3): 259-264, jun.-jul. 2010.
Article Dans Espagnol | LILACS | ID: lil-594985

Résumé

El incremento permanente a nivel mundial y en nuestro país del consumo de drogas ilegales y la posible asociación entre su consumo y el bruxismo son motivo de inquietud social y en particular de los odontólogos. En este estudio se presenta información actualizada de las distintas drogas de consumo habitual entre los adictos, los mecanismos bioquímicos generados a nivel orgánico en aquellos que las consumen y su posible asociación como factor causal de bruxismo.


Sujets)
Humains , Bruxisme , Substances illicites , Troubles liés à une substance , Alcoolisme/complications , /effets indésirables , Troubles liés aux amphétamines/complications
2.
Article Dans Anglais | IMSEAR | ID: sea-43846

Résumé

OBJECTIVES: To determine the perinatal impacts of heroin and amphetamine on both mothers and infants. MATERIAL AND METHOD: This is a retrospective study on the influence of amphetamine and heroin on pregnant women and their newborn infants at King Chulalongkorn Memorial Hospital in Bangkok, Thailand, between January 1997 and December 2002. The medical and demographic data of both mothers and infants were evaluated. Comparison of the consistent drug effects of these 2 drugs on the mothers and infants were also performed RESULTS: Two hundred and eleven women were identified There were 178 (84.4%) and 33 (15.6%) women addicted to amphetamine and heroin respectively. Sixty one (28.9%) of them were polydrug users. There were more polydrug users among heroin addicts than amphetamine addicts, (43.7% vs 27.2%, p < 0.05). Poor obstetric history were noted in both groups of women including lack of prenatal care (74.9%), a high incidence of previous abortion (22.3%), positive HIV serology test (11.1%), pre-eclampsia (5.2%), infection (3.3%) and antepartum hemorrhage (1.9%). Drug intoxication was found in 11 amphetamine addicted mothers, whereas 2 heroin addicts developed withdrawal symptoms during intrapartum and postpartum periods. All infants were singleton. There was one stillbirth and 2 neonatal deaths. There was no statistical difference in terms of sex ratio, mean birth weight, gestational age, length, head circumference and Apgar score between the groups of amphetamine and heroin exposed infants. The incidence of prematurity, low birth weight, IUGR and microcephaly were not statistically different between both groups of infants. The overall incidence was 31.7%, 31.7%, 9.5% and 8.6% respectively. Congenital anomalies were found in 5 (2.8%) amphetamine exposed infants. Thirty one out of 33 heroin exposed infants (93.9%) and 4 out of 178 amphetamine exposed infants (2.2%) developed drug withdrawal symptoms with the mean onset of 21.5 +/- 16.5 hours and 10.3 +/- 7.5 hours respectively, p > 0.05. All heroin withdrawal infants were successfully treated with Phenobarbital with the mean duration of treatment of 23.7 +/- 11.5 days. None of the amphetamine withdrawal infants needed specific treatment. They recovered spontaneously within 6.0 +/- 5.3 days. Eighteen infants were left in an orphanage or under the custody of their relatives. CONCLUSION: Amphetamine or heroin use during pregnancy can cause many serious adverse effects on both mothers and infants. The findings in the present study are consistent with previous reports, although they seemed to be more common and severe. Increasing awareness and improving understanding of drug abuse in the medical, legal and social aspects are needed in order to reduce these impacts.


Sujets)
Malformations dues aux médicaments et aux drogues/épidémiologie , Adulte , Troubles liés aux amphétamines/complications , Femelle , Dépendance à l'héroïne/complications , Humains , Protection infantile , Nourrisson à faible poids de naissance , Nouveau-né , Prématuré , Mâle , Protection maternelle , Échange foetomaternel , Syndrome de sevrage néonatal/épidémiologie , Soins périnatals , Grossesse , Complications de la grossesse/induit chimiquement , Issue de la grossesse , Études rétrospectives , Facteurs de risque , Thaïlande/épidémiologie
3.
Southeast Asian J Trop Med Public Health ; 2002 Dec; 33(4): 849-51
Article Dans Anglais | IMSEAR | ID: sea-31128

Résumé

Hepatitis C virus (HCV) is an infectious agent that has the potential to cause chronic liver disease, cirrhosis and hepatocellular carcinoma. We determined the prevalence and genotypes of HCV infection among groups of drug addicts: intravenous drug users (n = 134), methamphetamine users (n = 100), inhaled-drugs users (n = 19) and alcoholics (n = 50); a group of blood donors acted as a control. The control group consisted of 179 randomly-selected anti-HCV positive samples: these were subjected to HCV RNA screening and genotyping. The anti-HCV test was performed by ELISA: HCV RNA screening was by nested RT-PCR that employed primers from the 5' noncoding region. The genotype assay was based upon analysis of the 5' NCR amplified sequences and RFLP. Hepatitis C virus was highly prevalent among all groups of drug addicts (12-70%). In 2000. among the new blood donors (n = 66,340) at the National Blood Center, Thai Red Cross, anti-HCV prevalence amounted to 0.98%. The HCV genotype distribution showed that the most prevalent genotype was 3a, followed by 1b and 6a. Our data demonstrated the very high prevalence of HCV infection in IVDUs, a finding that is consistent with the blood-borne nature of the virus. In order to curb HCV infection, a determined effort to educate both the general population and high-risk groups is required; such a program of education would address both general and particular methods of transmission, especially the use of non-sterile needles etc.


Sujets)
Alcoolisme/complications , Troubles liés aux amphétamines/complications , Donneurs de sang/statistiques et données numériques , Test ELISA , Génotype , Éducation pour la santé , Hepacivirus/classification , Hépatite C/épidémiologie , Humains , Dépistage de masse , Métamfétamine , Partage de seringue/statistiques et données numériques , Évaluation des besoins , Surveillance de la population , ARN viral/analyse , RT-PCR , Facteurs de risque , Études séroépidémiologiques , Toxicomanie intraveineuse/complications , Thaïlande/épidémiologie
4.
In. Timerman, Ari; Machado César, Luiz Antonio; Ferreira, Joäo Fernando Monteiro; Bertolami, Marcelo Chiara. Manual de Cardiologia: SOCESP. Säo Paulo, Atheneu, 2000. p.550-2, tab.
Monographie Dans Portugais | LILACS | ID: lil-265479
SÉLECTION CITATIONS
Détails de la recherche